BridgeBio Pharma
BBIO
#2216
Rank
โ‚น600.41 B
Marketcap
โ‚น3,177
Share price
-0.31%
Change (1 day)
6.69%
Change (1 year)

Revenue for BridgeBio Pharma (BBIO)

Revenue in 2024 (TTM): โ‚น18.15 Billion

According to BridgeBio Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚น18.85 Billion. In 2023 the company made a revenue of โ‚น0.77 Billion a decrease over the revenue in the year 2022 that were of โ‚น6.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BridgeBio Pharma from 2018 to 2024

20192020202120222023โ‚น5Bโ‚น10Bโ‚น15Bโ‚น20B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น18.15 B2244.67%
2023 โ‚น0.77 B-87.95%
2022 โ‚น6.42 B23.83%
2021 โ‚น5.18 B760.14%
2020 โ‚น0.60 B-79.14%
2019 โ‚น2.89 B
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น19.56 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น61.60 B 226.69%๐Ÿ‡บ๐Ÿ‡ธ USA